These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38605116)

  • 1. FDA approves first complement factor D inhibitor.
    Mullard A
    Nat Rev Drug Discov; 2024 May; 23(5):329. PubMed ID: 38605116
    [No Abstract]   [Full Text] [Related]  

  • 2. FDA approves first telomerase inhibitor.
    Mullard A
    Nat Rev Drug Discov; 2024 Aug; 23(8):570. PubMed ID: 38877327
    [No Abstract]   [Full Text] [Related]  

  • 3. FDA approves new drug to prevent hereditary angioedema attacks.
    Lavine G
    Am J Health Syst Pharm; 2008 Nov; 65(22):2080. PubMed ID: 18997129
    [No Abstract]   [Full Text] [Related]  

  • 4. FDA approves first-in-class AKT inhibitor.
    Mullard A
    Nat Rev Drug Discov; 2024 Jan; 23(1):9. PubMed ID: 38049466
    [No Abstract]   [Full Text] [Related]  

  • 5. FDA approves an HDAC inhibitor for Duchenne muscular dystrophy.
    Mullard A
    Nat Rev Drug Discov; 2024 May; 23(5):329. PubMed ID: 38605117
    [No Abstract]   [Full Text] [Related]  

  • 6. FDA approves PI3K inhibitor for a rare immune disorder.
    Mullard A
    Nat Rev Drug Discov; 2023 May; 22(5):342. PubMed ID: 37041237
    [No Abstract]   [Full Text] [Related]  

  • 7. FDA approves first-in-class HIV capsid inhibitor.
    Mullard A
    Nat Rev Drug Discov; 2023 Feb; 22(2):90. PubMed ID: 36627443
    [No Abstract]   [Full Text] [Related]  

  • 8. FDA approves first immunotherapy drug for nasopharyngeal carcinoma.
    Nierengarten MB
    Cancer; 2024 Jun; 130(11):1903. PubMed ID: 38757625
    [No Abstract]   [Full Text] [Related]  

  • 9. FDA approves 100th monoclonal antibody product.
    Mullard A
    Nat Rev Drug Discov; 2021 Jul; 20(7):491-495. PubMed ID: 33953368
    [No Abstract]   [Full Text] [Related]  

  • 10. FDA Approves Vilobelimab for Emergency Use in Hospitalized Adults.
    Harris E
    JAMA; 2023 May; 329(18):1544. PubMed ID: 37075230
    [No Abstract]   [Full Text] [Related]  

  • 11. FDA approves PARP inhibitor for ovarian cancer.
    Nat Biotechnol; 2017 May; 35(5):398. PubMed ID: 28486465
    [No Abstract]   [Full Text] [Related]  

  • 12. FDA approves first drug for Parkinson disease psychosis.
    Mullard A
    Nat Rev Drug Discov; 2016 Jun; 15(6):375. PubMed ID: 27245388
    [No Abstract]   [Full Text] [Related]  

  • 13. FDA center issues new guidelines, approves drugs.
    Printz C
    Cancer; 2021 Mar; 127(6):826. PubMed ID: 33689177
    [No Abstract]   [Full Text] [Related]  

  • 14. FDA approves first MASH drug.
    Nat Biotechnol; 2024 Apr; 42(4):540. PubMed ID: 38632447
    [No Abstract]   [Full Text] [Related]  

  • 15. FDA approves new antipsychotic.
    Traynor K
    Am J Health Syst Pharm; 2007 Feb; 64(3):222. PubMed ID: 17244863
    [No Abstract]   [Full Text] [Related]  

  • 16. FDA approves first drug in new class of antibiotics.
    Senior K
    Lancet; 2000 Apr; 355(9214):1523. PubMed ID: 10801180
    [No Abstract]   [Full Text] [Related]  

  • 17. FDA approves levoleucovorin.
    Traynor K
    Am J Health Syst Pharm; 2008 Apr; 65(8):686. PubMed ID: 18387890
    [No Abstract]   [Full Text] [Related]  

  • 18. FDA approves first drug in new treatment category.
    AIDS Policy Law; 2003 Mar; 18(6):3. PubMed ID: 12712927
    [No Abstract]   [Full Text] [Related]  

  • 19. FDA notifications. FDA approves new Kaletra formulation.
    AIDS Alert; 2005 Dec; 20(12):142-3. PubMed ID: 16400722
    [No Abstract]   [Full Text] [Related]  

  • 20. FDA approves first Parkinson's patch.
    Thompson CA
    Am J Health Syst Pharm; 2007 Jun; 64(12):1244. PubMed ID: 17563040
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.